Securing analytical documentation is essential when evaluating growth hormone secretagogues for in vitro and preclinical research models. PX1 Research provides batch-specific documentation for every lot of Ipamorelin 50mg, ensuring chemical purity, molecular weight verification, and minimal endotoxin levels across all research applications.
Securing analytical documentation is essential when evaluating growth hormone secretagogues for in vitro and preclinical research models. PX1 Research provides batch-specific documentation for every lot of Ipamorelin 50mg, ensuring chemical purity, molecular weight verification, and minimal endotoxin levels across all research applications.
Ordering ipamorelin with COA (Certificate of Analysis) provides laboratory researchers with verified documentation confirming peptide identity, chemical purity, and endotoxin levels. High-grade research Ipamorelin features >99% purity confirmed via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS), ensuring reproducible data in growth hormone secretagogue assays without confounding impurities.
When designing controlled preclinical experiments, reliance on unverified peptides risks introducing unknown synthesis side-products, residual solvents, or truncated amino acid sequences that distort receptor binding kinetics. Selecting fully documented reagents like our Ipamorelin 50mg ensures that experimental outcomes reflect the true pharmacological action of the target compound rather than baseline batch variations.
Ipamorelin is a synthetic pentapeptide with the sequence Aib-His-D-2Nal-D-Phe-Lys-NH2. Recognized as one of the most selective growth hormone secretagogues (GHS) available for laboratory investigation, it functions as a potent agonist at the ghrelin/growth hormone secretagogue receptor (GHS-R1a). Preclinical research indicates that Ipamorelin mimics the natural GH-releasing activity of ghrelin, binding to GHS-R1a receptors within anterior pituitary tissue and hypothalamic nerve terminals to stimulate pulsatile growth hormone secretion.
Unlike earlier generations of peptide secretagogues, Ipamorelin exhibits high receptor selectivity. In vitro pituitary cell culture models demonstrate that while Ipamorelin stimulates somatotrophs to release growth hormone in a dose-dependent manner, it does not trigger a significant rise in adrenocorticotropic hormone (ACTH), cortisol, or prolactin secretion. This selective mechanism makes Ipamorelin a foundational tool in growth hormone secretagogues research, allowing investigators to isolate GH pathways without cross-reactivity from stress axis activation.
A rigorous Certificate of Analysis serves as an essential quality assurance document for institutional buying departments and laboratory principal investigators. A complete COA for Ipamorelin with COA must include detailed quantitative reporting from an independent, ISO 17025 accredited analytical facility rather than in-house manufacturer claims.
Key analytical metrics reported on a PX1 Research COA include:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Establishes chromatographic purity by separating the main peptide peak from residual synthesis fragments or degradation products. PX1 sets a strict standard of >99% area purity.
2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular mass. The observed mass peak must match the theoretical monoisotopic mass of Ipamorelin (711.86 g/mol) to verify correct sequence assembly.
3. Bacterial Endotoxin Analysis: Measured via Chromogenic Limulus Amebocyte Lysate (LAL) assay to confirm endotoxin levels fall well below <0.01 EU/mg, preventing non-specific inflammatory responses in cell culture or animal assays.
To review additional methodology behind our analytical standards, explore our guide on peptide purity testing.
To ensure complete transparency and data reproducibility across experimental trials, PX1 Research adheres to stringent quality criteria that exceed industry standards for laboratory reagents:
• Purity Verification: >99% area purity determined via RP-HPLC column chromatography.
• Identity Confirmation: High-resolution ESI-MS verifying exact molecular weight (711.86 g/mol).
• Endotoxin Control: LAL assay reporting <0.01 EU/mg per vial.
• Facility Compliance: Manufactured in domestic USA facilities adhering to strict GMP guidelines.
• Testing Accreditation: Independent analysis executed by certified third-party ISO/IEC 17025 laboratories.
• Lot Traceability: Every vial features clear batch coding directly linked to a public COA.
• Rapid Distribution: Same-day shipping for orders placed Monday through Friday from our California and Arizona logistics hubs.
By enforcing these criteria across our entire catalog, researchers can reliably source compounds across our all peptides inventory with full analytical verification.
When structuring comparative growth axis assays, researchers frequently evaluate Ipamorelin against other synthetic secretagogues and growth hormone releasing hormone (GHRH) analogs. In preclinical literature, Ipamorelin is regularly compared to CJC-1295 No DAC 5mg, GHRP-2 5mg, GHRP-6 5mg, and Sermorelin 5mg.
While GHRP-2 and GHRP-6 display robust GH-releasing potency, preclinical assays demonstrate that both compounds induce concurrent elevations in plasma cortisol and prolactin by activating broader neuroendocrine signaling pathways. Conversely, Ipamorelin provides targeted GHS-R1a stimulation without elevating cortisol or prolactin, even at higher concentrations in animal models. When paired with GHRH analogs like CJC-1295 or Sermorelin in vitro, Ipamorelin demonstrates synergetic GH output by acting on complementary receptor sites—GHS-R1a and GHRH-R respectively.
To preserve structural integrity and prevent peptide aggregation, proper reconstitution technique is imperative when preparing lyophilized Ipamorelin 50mg for laboratory assays. Reconstitution should always take place under a laminar flow hood using sterile laboratory technique.
1. Solvent Selection: Bacteriostatic water (0.9% benzyl alcohol) or sterile 0.9% sodium chloride for injection is recommended depending on downstream assay compatibility.
2. Diluent Addition: Direct the stream of solvent down the inner glass wall of the vial rather than splashing directly onto the lyophilized cake. Allow the diluent to gently wick into the powder.
3. Dissolution: Allow the vial to sit at room temperature for 5–10 minutes. Swirl gently in a smooth circular motion. Never vortex or aggressively shake peptide solutions, as mechanical shear stress can disrupt tertiary structure and induce peptide aggregation.
4. Working Concentration: For standard micro-pipetting, reconstituting a 50mg vial with 5 mL or 10 mL of diluent yields working stock concentrations of 10 mg/mL or 5 mg/mL, respectively.
Lyophilized Ipamorelin is stable at room temperature for short transport periods but should be stored long-term in a desiccated freezer at -20°C to -80°C upon receipt to maintain maximum potency.
Once reconstituted into aqueous solution, the peptide is susceptible to hydrolysis and oxidation. Reconstituted stocks should be stored at 2°C to 8°C and utilized within 21 to 30 days. For long-term preclinical studies, investigators should aliquot reconstituted solutions into single-use sterile polypropylene micro-centrifuge tubes and store at -80°C to prevent repeated freeze-thaw cycles, which degrade peptide purity.
In vitro and animal models utilize Ipamorelin to investigate diverse physiological pathways governed by growth hormone dynamics. Prominent areas of ongoing study include:
• Pituitary Somatotroph Kinetics: Quantifying growth hormone pulse frequency and amplitude in primary pituitary cell culture preparations.
• Bone Mineralization & Turnover: Investigating osteoblast proliferation and collagen deposition in rodent models of bone density loss.
• Muscle Protein Synthesis: Analyzing mTOR pathway activation and nitrogen retention under catabolic experimental conditions.
• Gastrointestinal Motility: Studying ghrelin-receptor mediated gastric emptying dynamics in animal model preparations.
Researchers seeking detailed scientific background on these experimental frameworks can explore our centralized research hub for updated literature reviews and technical bulletins.
PX1 Research supports university laboratories, contract research organizations (CROs), and biotechnology firms requiring consistent batch-to-batch consistency for long-term study protocols. Large-scale projects benefit from dedicated lot reservation, ensuring all experimental cohorts utilize peptides synthesized from the exact same master lot.
Principal investigators and procurement officers requiring high-volume supplies can establish a verified institutional account via our wholesale portal to receive bulk pricing, dedicated account management, and custom analytical reporting.
What does an ipamorelin with coa report confirm?
An ipamorelin with COA (Certificate of Analysis) confirms the precise chemical purity (via RP-HPLC), exact molecular weight identity (via mass spectrometry), and freedom from high endotoxin levels (via LAL testing) for a specific production lot.
How is purity determined on an ipamorelin certificate of analysis?
Purity is determined using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). The main peptide peak area is integrated against minor impurity peaks to calculate a net purity percentage, with PX1 Research requiring >99% purity.
Why is endotoxin testing critical for ipamorelin research?
Endotoxins (lipopolysaccharides) induce systemic inflammatory cascades and cytokine release in cell cultures or animal models. Low endotoxin levels (<0.01 EU/mg) ensure experimental observations are caused by Ipamorelin, not bacterial contamination.
How does Ipamorelin differ selectively from GHRP-6 and GHRP-2 in vitro?
In vitro studies show Ipamorelin selectively stimulates growth hormone release without causing significant spikes in cortisol, adrenocorticotropic hormone (ACTH), or prolactin, whereas GHRP-2 and GHRP-6 stimulate elevated cortisol and prolactin levels.
What is the recommended laboratory reconstitution protocol for Ipamorelin 50mg?
Reconstitute using sterile bacteriostatic water by slowly introducing diluent down the side of the vial. Allow passive dissolution without vortexing or aggressive shaking to protect the tertiary peptide structure.
How should lyophilized Ipamorelin 50mg vials be stored long term?
Lyophilized vials should be stored desiccated at -20°C to -80°C for long-term stability. Reconstituted liquid stocks should be kept at 2°C to 8°C for short-term use or aliquoted and stored at -80°C.
What analytical testing methods are used to verify Ipamorelin identity?
Identity is verified via Electrospray Ionization Mass Spectrometry (ESI-MS) to match the monoisotopic molecular weight of 711.86 g/mol, alongside RP-HPLC retention time comparison.
Does PX1 Research provide lot-specific COAs for every order?
Yes. Every batch of Ipamorelin 50mg shipped by PX1 Research includes access to a lot-specific Certificate of Analysis generated by an independent ISO 17025 accredited laboratory.
Can Ipamorelin be combined with CJC-1295 in preclinical secretagogue models?
Yes, in vitro and preclinical rodent models frequently combine GHS-R1a agonists like Ipamorelin with GHRH analogs like CJC-1295 to study synergistic amplification of growth hormone secretion.
How quickly are Ipamorelin orders fulfilled for institutional research accounts?
PX1 Research dispatches orders placed Monday through Friday on the same day from our distribution centers in California and Arizona to minimize laboratory downtime.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.